Sanofi and BioMed X Partner to Predict Efficacy with Virtual Patient Populations

BioMed X and Sanofi have inked an R&D collaboration to use digital data and artificial intelligence to predict the efficacy of first-in-class drug candidates using virtual patient populations, BioMed X announced Monday.